相关实验视频
Updated: Jan 13, 2026
07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
6.1K
血蛋白生物标志物用于检测早期胃前和癌症:一项前性研究
Quentin Giai Gianetto1,2, Valérie Michel3, Thibaut Douché1
1Institut Pasteur, Université Paris Cité, UAR CNRS 2024, Proteomics Core Facility, MSBio, 75015 Paris, France.
International journal of molecular sciences
|October 29, 2025
概括
这项研究确定了用于早期检测胃癌的新型血液蛋白生物标志物. 一个简单的血液检测可以显著改善这种经常无症状的疾病的诊断和患者的结果.
科学领域:
- 蛋白质组学是指蛋白质组学.
- 生物标志物发现发现
- 在瘤学瘤学.
背景情况:
- 由于检测迟到,胃癌 (GC) 的预后不好.
- 目前的诊断方法如内镜是侵入性的,对早期病变的敏感性有限.
- 基于血液的非侵入性蛋白质生物标志物为早期检测胃病变提供了一个有希望的替代方案.
研究的目的:
- 识别和验证血蛋白生物标记物,用于早期检测胃 preneoplasia 和癌症.
- 开发预测模型,以使用最小的生物标志物集来区分不同的胃病.
主要方法:
- 在一个探索性队列 (n=39) 中,利用基于质谱的蛋白质组学进行前性研究.
- 在较大的队列中 (n=138) 使用酶相关免疫吸收试验 (ELISA) 验证候选生物标志物.
- 基于已识别的蛋白质面板的预测模型的开发和评估.
主要成果:
- 为了区分患者类别,确定了15个有前途的蛋白质候选者.
- 一个由四个蛋白质组成的小组实现了高分类性能 (94.1-98.2%AUROC) 来区分癌症和非癌症.
- 一个由五种蛋白质组成的小组表现出色 (97.3-99.5%AUROC) 在区分癌症/脑新生病与健康病例或胃炎病例方面.
结论:
- 一种基于血液的蛋白质生物标志物策略显示出对非侵入性早期检测胃病变,包括无症状阶段的显著前景.
- 这种方法可以提高胃癌的早期检测和临床管理.
- 鉴定到的生物标志物提供了一个潜在的工具,通过及时干预来改善患者的治疗结果.
相关概念视频
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
532
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
532
01:30Serum Laboratory Studies, Stool Test, Breath Test
746
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
746